Developing a multi-purpose moisture meter on ultra high frequency.

The article deals with the problems of optimizing the design and structure of the moisture meter, which generally reduces to minimizing measurement errors by selecting the type of sample former and its basic parameters. The constructive, structural and algorithmic optimization methods proposed in the article allow to create a single unified complex of means for controlling the moisture content of fibrous and solid bulk materials that were used in the development of a multi-purpose microwave moisture meter for fibrous materials and granular products of the agro-industrial complex

2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty

Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/137769/1/art40149.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/137769/2/art40149_am.pd

2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty

Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/137753/1/acr23274.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/137753/2/acr23274_am.pd

2020 American College of Rheumatology Guideline for the Management of Gout

Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/155484/1/art41247.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/155484/2/art41247_am.pd

2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases

Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/154675/1/art41191.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/154675/2/art41191_am.pd

METROLOGICAL CERTIFICATION AND TEST CONDITIONS FOR VERIFICATION EQUIPMENT

The article analyzes the metrological certification and test conditions for verification equipment. The main tasks of metrological certification, test conditions, accuracy characteristics of verification equipment, primary, repeated and periodic, expert and inspection certification of verification equipment are considered in the article. Besides, the major tasks of the testing equipment certification are considered as well. They are: establishing the current testing equipment eligibility in accordance with its purpose, establishing the actual reproducibility values of test conditions implemented by testing equipment and assessing the technical characteristics compliance of testing equipment with the safety, hygienic and other special requirement

Comparison of theoretical and experimental geometric characteristics of betulin

The study of betulin and its derivatives is of great importance, since the programs of mathematical modeling enable a qualitative study of the relationship between structure-spectrum-properties. As a result of the theoretical search, it is possible to determine still non-synthesized highly-biologically active derivatives of betuli

Morphologıcal characteristics of different wild Berberis sphaerocarpa Kar. et Kir. genotypes grown in Jeti-Oguz District (Issyk-Kul Province) of North Eastern Kyrgyzstan

Today, several fruit species are used for different purposes in alternative medicine. Among those species, barberry species are commonly used in treatment of various diseases. Jeti-Oguz District of Issyk Kul located around Issyk Lake in North-east of Kyrgyzstan has a unique flora and wild Berberis sphaerocarpa Kar. et Kit. (spherical-fruited barberry) species have a great place in regional flora. The fruits, leaves and roots of these species are commonly used by local people as functional products in alternative medicine. The most significant parameter in this wild population is the morphological variation in fruits and leaves. In this study, pomological analyses were performed on ripened black fruits of 26 wild genotypes. Pomological analyses yielded the fruit weights as between 0.23 g (01-JO-006) and 0.61 g (01-JO-025); total soluble solids as between 16.67% (01-JO-014) and 18.73% (01-JO-010 and 01-JO-018). Fruit shapes of genotypes were identified as long, long-spherical, spherical and oblate spherical. Significant variations were observed in morphological characteristics of spherical-fruited barberry genotypes through pomological analyses and field observations

2018 American College of Rheumatology/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis

Objective. To develop an evidence- based guideline for the pharmacologic and nonpharmacologic treatment of psoriatic arthritis (PsA), as a collaboration between the American College of Rheumatology (ACR) and the National Psoriasis Foundation (NPF). Methods. We identified critical outcomes in PsA and clinically relevant PICO (population/intervention/compara-tor/outcomes) questions. A Literature Review Team performed a systematic literature review to summarize evidence supporting the benefits and harms of available pharmacologic and nonpharmacologic therapies for PsA. GRADE (Grading of Recommendations Assessment, Development and Evaluation) methodology was used to rate the quality of the evidence. A voting panel, including rheumatologists, dermatologists, other health professionals, and patients, achieved consensus on the direction and the strength of the recommendations. Results. The guideline covers the management of active PsA in patients who are treatment- naive and those who con-tinue to have active PsA despite treatment, and addresses the use of oral small molecules, tumor necrosis factor inhibitors, interleukin- 12/23 inhibitors (IL- 12/23i), IL- 17 inhibitors, CTLA4- Ig (abatacept), and a JAK inhibitor (tofaciti nib). We also de-veloped recommendations for psoriatic spondylitis, predominant enthesitis, and treatment in the presence of concomitant inflammatory bowel disease, diabetes, or serious infections. We formulated recommendations for a treat- to- target strategy, vaccinations, and nonpharmacologic therapies. Six percent of the recommendations were strong and 94% conditional, indi-cating the importance of active discussion between the health care provider and the patient to choose the optimal treatment. Conclusion. The 2018 ACR/NPF PsA guideline serves as a tool for health care providers and patients in the selection of appropriate therapy in common clinical scenarios. Best treatment decisions consider each individual patient situation. The guideline is not meant to be proscriptive and should not be used to limit treatment options for patients with PsA

2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis.

ObjectiveTo develop recommendations for prevention and treatment of glucocorticoid-induced osteoporosis (GIOP).MethodsWe conducted a systematic review to synthesize the evidence for the benefits and harms of GIOP prevention and treatment options. The Grading of Recommendations Assessment, Development and Evaluation methodology was used to rate the quality of evidence. We used a group consensus process to determine the final recommendations and grade their strength. The guideline addresses initial assessment and reassessment in patients beginning or continuing long-term (≥3 months) glucocorticoid (GC) treatment, as well as the relative benefits and harms of lifestyle modification and of calcium, vitamin D, bisphosphonate, raloxifene, teriparatide, and denosumab treatment in the general adult population receiving long-term GC treatment, as well as in special populations of long-term GC users.ResultsBecause of limited evidence regarding the benefits and harms of interventions in GC users, most recommendations in this guideline are conditional (uncertain balance between benefits and harms). Recommendations include treating only with calcium and vitamin D in adults at low fracture risk, treating with calcium and vitamin D plus an additional osteoporosis medication (oral bisphosphonate preferred) in adults at moderate-to-high fracture risk, continuing calcium plus vitamin D but switching from an oral bisphosphonate to another antifracture medication in adults in whom oral bisphosphonate treatment is not appropriate, and continuing oral bisphosphonate treatment or switching to another antifracture medication in adults who complete a planned oral bisphosphonate regimen but continue to receive GC treatment. Recommendations for special populations, including children, people with organ transplants, women of childbearing potential, and people receiving very high-dose GC treatment, are also made.ConclusionThis guideline provides direction for clinicians and patients making treatment decisions. Clinicians and patients should use a shared decision-making process that accounts for patients' values, preferences, and comorbidities. These recommendations should not be used to limit or deny access to therapies